Võrdle meetodeid
Vaata valitud meetodeid kõrvuti; erinevad read on esile tõstetud.
| PRISMA Checklist× | CONSORT Reporting Checklist× | |
|---|---|---|
| Valdkond | Uurimismetodoloogia | Uurimismetodoloogia |
| Perekond | Process / pipeline | Process / pipeline |
| Tekkeaasta≠ | 2021 (original 2009) | 2010 (original 1996) |
| Looja≠ | Page et al. (PRISMA Group) | Schulz et al. (CONSORT Group) |
| Tüüp≠ | Systematic review author reporting checklist | Trial author reporting checklist |
| Algallikas≠ | Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372, n71. DOI ↗ | Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. The Lancet, 375(9721), 1657–1668. DOI ↗ |
| Rööpnimetused | PRISMA, PRISMA 2020 | CONSORT, CONSORT 2010 |
| Seotud | 4 | 4 |
| Kokkuvõte≠ | PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is a 27-item evidence-based checklist published in 2021 (updated from 2009) to standardize reporting of systematic reviews and meta-analyses. Endorsed by over 500 journals, PRISMA is the international standard for evidence synthesis reporting, used across healthcare, psychology, education, and social sciences to ensure transparency and reproducibility. | The CONSORT (Consolidated Standards of Reporting Trials) Statement is a 25-item evidence-based checklist and flow diagram developed to standardize reporting of parallel-group randomized controlled trials. First published in 1996 and updated in 2010 (CONSORT 2010), it is endorsed by over 600 journals including The Lancet, JAMA, and BMJ, and is mandatory or strongly recommended for RCT manuscript submission across clinical research. |
| ScholarGateAndmestik ↗ |
|
|